🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NYK
$NYKD.OL
🔒 EuropeNykode Therapeutics ASA
AVG HISTORICAL GAP
-1.72%
MAX GAP RECORD
-33.27%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NYKD.OL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NYKD.OL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 26, 2026 Earnings Release 2026-08-26 (AFTER CLOSE) |
+8.59%
|
| Nov 24, 2025 Earnings Release 2025-11-24 (BEFORE OPEN) |
+2.26%
|
| Aug 27, 2025 Earnings Release 2025-08-27 (BEFORE OPEN) |
+1.16%
|
| May 28, 2025 Earnings Release 2025-05-28 (BEFORE OPEN) |
+4.11%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (BEFORE OPEN) |
-1.33%
|
| Nov 27, 2024 Earnings Release 2024-11-27 (BEFORE OPEN) |
-5.35%
|
| Aug 21, 2024 Earnings Release 2024-08-21 (BEFORE OPEN) |
-33.27%
|
| May 14, 2024 Earnings Release 2024-05-14 (BEFORE OPEN) |
+1.28%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.0%
Bullish Gaps (7)
Bearish Gaps (6)
Neutral / Flat (0)
📖 Intelligence Summary
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗